Companies / Canada
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Patheon Moves To Stem Loses
December 2007 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
Canadian contract drugmaker Patheon has bitten the bullet and put its loss making plant in Carolina, Puerto Rico up for sale, much to the relief of BMI. Rightly in our opinion, the company has seen the difficulties at the plant as product-specific rather than as a failure of the company's restructuring drive as a whole and chosen to retain its two other plants on the island - at Caguas and Manati - for the time